226
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Dose Effect of Botulinum Toxin A in Heterotropia and Heterophoria

, PhD, DBO, , FRCOphth, FRCSI & , FRCOphth
Pages 3-7 | Received 22 Jan 2009, Accepted 15 Nov 2009, Published online: 15 Mar 2010
 

Abstract

Purpose: To evaluate the short-term dose effect of botulinum toxin in manifest and intermittent horizontal strabismus types.

Methods: Dysport of 2 international units was injected into a single muscle in cases of constant esotropia and exotropia plus decompensating esophoria and exophoria. Electromyography (EMG) signal was recorded during each procedure. Angle of deviation was measured in each case pretreatment and posttreatment at 2 weeks by prism cover test for near and distance fixation. Change in deviation was evaluated by nonparametric statistical evaluation.

Results: Sixty-six patients were reviewed: 30 males and 36 females. The mean age was 24 years (1-79: SD 20.4). Of the 66 patients, 28 had botulinum toxin to the right eye and 38 had it to the left eye. Thirty-nine had eso deviations (19 constant, 20 intermittent) and 27 had exo deviations (12 constant, 15 intermittent). EMG signal was classed as excellent (30%), good (26%), low (6%), or absent (38%). Percentage net change in angle of deviation was 52% to 60% for eso and exo deviations at near and distance fixation. No association was found in extent of reduction of angle of deviation for type of deviation, presence of constant or intermittent deviation, eye injected, or EMG signal.

Conclusions: All changes in angle of deviation were significant. Larger pretreatment angles of deviation did not preclude significant changes in angle of deviation using botulinum toxin and significantly greater change in deviation was seen in pretreatment angles greater than 20PD.

ACKNOWLEDGMENT

This article is based on a study first reported in the Transactions of the 32nd European Strabismological Association, Munich, Germany, 2008.

Declaration of Interest: There are no conflicts of interest for the authors. The authors alone are responsible for the content of the article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.